Journal of Neuro-Oncology

, Volume 94, Issue 2, pp 221–226 | Cite as

Stroke in cancer patients: a risk factor analysis

  • Oberndorfer StefanEmail author
  • Nussgruber Vera
  • Berger Otto
  • Lahrmann Heinz
  • Grisold Wolfgang
Clinical Study - Paient Study


Background and Purpose In patients already suffering from cancer, the additional occurrence of stroke can aggravate the burden of the disease. The purpose of this study was to compare risk factors for haemorrhagic and ischemic strokes in cancer and non-cancer patients. Methods A retrospective analysis, including 1,274 stroke patients admitted to a stroke unit, was conducted from 2004 to 2007. Classical risk factors for stroke and clinical outcome measures were compared between cancer and non-cancer patients. Results Twelve percent of stroke patients had an additional diagnosis of cancer. In the non-cancer population, 84% had ischemic and 16% had haemorrhagic strokes. In cancer patients, 86% had ischemic and 14% had haemorrhagic strokes. Vascular risk factors in cancer patients, including hypertension, atrial fibrillation, coronary vessel disease, smoking, hypercholesterolemia and diabetes mellitus, showed no difference compared to the non-cancer population. Only thrombotic events occurred more often in the cancer cohort. The most frequent cancer types were urogenital, breast and gastrointestinal. Regarding clinical outcome, cancer patients had an inferior neurological condition at discharge and a trend towards a longer stay in the stroke unit. Conclusions The frequency of ischemic and haemorrhagic stroke in tumour patients is similar to that in the non-cancer population. Cerebrovascular risk factors do not significantly vary between cancer and non-cancer patients. The higher frequency of thrombotic events in cancer patients may reflect a coagulation disorder, commonly found in patients with malignancy. Clinical outcome in cancer patients may be worsened by the pre-existent co-morbidity.


Cerebrovascular risk factors Neurooncology Stroke and cancer 



This work was supported by funding from the European Community’s Sixth Framework Programme (Contract LSSM-CT-2005-518174). It reflects only the authors’ views and the Community is not liable for any use that may be made of the information contained herein.


  1. 1.
    Clouston PD, DeAngelis LM, Posner JB (2006) The spectrum of neurological disease in patients with systemic cancer. Ann Neurol 31:268–273. doi: 10.1002/ana.410310307 CrossRefGoogle Scholar
  2. 2.
    Graus F, Rogers LR, Posner JB (1985) Cerebrovascular complications in patients with cancer. Medicine (Baltimore) 64:16–35. doi: 10.1097/00005792-198501000-00002 Google Scholar
  3. 3.
    Posner JB (1995) Vascular disorders. In: Posner JB (ed) Neurologic complications of cancer. Davies, Philadelphia, pp 199–299Google Scholar
  4. 4.
    Lindvig K, Moller H, Mosbech J, Jensen OM (1990) The pattern of cancer in a large cohort of stroke patients. Int J Epidemiol 19:498–504. doi: 10.1093/ije/19.3.498 PubMedCrossRefGoogle Scholar
  5. 5.
    Rogers LR (1994) Cerebrovascular complications in cancer patients. Oncology 8:23–30; Williston ParkPubMedGoogle Scholar
  6. 6.
    The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators (1998) Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. JAMA 279:1265–1272CrossRefGoogle Scholar
  7. 7.
    Chaturvedi S, Ansell J, Recht L (1994) Should cerebral ischemic events in cancer patients be considered a manifestation of hypercoagulability? Stroke 25:1215–1218PubMedGoogle Scholar
  8. 8.
    Zhang YY, Cordato D, Shen Q, Sheng AZ, Hung WT, Chan DK (2006) Risk factor, pattern, etiology and outcome in ischemic stroke patients with cancer: a nested case-control study. Cerebrovasc Dis 23:181–187. doi: 10.1159/000097639 PubMedCrossRefGoogle Scholar
  9. 9.
    Yashin AI, Ukraintseva SV, Akushevich IV, Arbeev KG, Kulminski A, Akushevich L (2008) Trade-off between cancer and aging: what role do other diseases play? Evidence from experimental and human population studies. Mech Ageing Dev :25. (Epub ahead of print)Google Scholar
  10. 10.
    Cestari DM, Weine DM, Panageas KS, Segal AZ, De Angelis LM (2004) Stroke in patients with cancer: incidence and aetiology. Neurology 64:2025–2030Google Scholar
  11. 11.
    Zhang YY, Chan DKY, Cordato D, Sheng AZ (2006) Stroke risk factor, pattern and outcome in patients with cancer. Acta Neurol Scand 114:378–383. doi: 10.1111/j.1600-0404.2006.00709.x PubMedCrossRefGoogle Scholar
  12. 12.
    Grisold W, Oberndorfer S, Struhal W (2009) Stroke and cancer: a review. Acta Neurol Scand 119:1–16. doi: 10.1111/j.1600-0404.2008.01059.x PubMedCrossRefGoogle Scholar
  13. 13.
    Kune GA, Kune S, Watson LF (2007) Colorectal cancer risk, chronic illnesses, operations and medications: case control results from the Melbourne Colorectal Cancer Study 1988. Int J Epidemiol 6:951–957. doi: 10.1093/ije/dym193 CrossRefGoogle Scholar
  14. 14.
    Li SH, Chen WH, Tang Y, Rau KM, Chen YY, Huang TL et al (2006) Incidence of ischemic stroke post-chemotherapy: a retrospective review of 10,963 patients. Clin Neurol Neurosurg 108:150–156. doi: 10.1016/j.clineuro.2005.03.008 PubMedCrossRefGoogle Scholar
  15. 15.
    Chan AT, Leung WT, Johnson PJ (1994) Cerebrovascular event following taxol infusion. Clin Oncol (R Coll Radiol) 6:202–203. doi: 10.1016/S0936-6555(94)80062-6 Google Scholar
  16. 16.
    Ohashi S, Yazumi S, Nishio A et al (2006) Acute cerebral infarction during combination chemotherapy with s-1 and cisplatin for a young patient with a mucin-producing adenocarcinoma of the stomach. Intern Med 45:1049–1053. doi: 10.2169/internalmedicine.45.1720 PubMedCrossRefGoogle Scholar
  17. 17.
    Rollins N, Winick N, Bash R et al (2004) Acute methotrexate neurotoxicity: findings on diffusion-weighted imaging and correlation with clinical outcome. AJNR Am J Neuroradiol 25:1688–1695PubMedGoogle Scholar
  18. 18.
    Braithwaite RS, Chlebowski RT, Lau J, George S, Hess R, Col NF (2003) Meta-analysis of vascular and neoplastic events associated with tamoxifen. J Gen Intern Med 18:937–947. doi: 10.1046/j.1525-1497.2003.20724.x PubMedCrossRefGoogle Scholar
  19. 19.
    Bushnell CD, Goldstein LB (2004) Risk of ischemic stroke with tamoxifen treatment for breast cancer: a meta-analysis. Neurology 63:1230–1233PubMedGoogle Scholar
  20. 20.
    Rogers LR (2004) Cerebrovascular complications in patients with cancer. Semin Neurol 24:453–460. doi: 10.1055/s-2004-861539 PubMedCrossRefGoogle Scholar
  21. 21.
    Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics 2007. CA Cancer J Clin 57:43–66. doi: 10.3322/canjclin.57.1.43 PubMedCrossRefGoogle Scholar
  22. 22.
    Hiatt BK, Lentz SR (2002) Prothrombotic states that predispose to stroke. Curr Treat Options Neurol 4:417–425. doi: 10.1007/s11940-002-0009-1 PubMedCrossRefGoogle Scholar
  23. 23.
    Lee AY (2002) Cancer and thromboembolic disease: pathogenic mechanisms. Cancer Treat Rev 28:137–140. doi: 10.1016/S0305-7372(02)00044-0 PubMedCrossRefGoogle Scholar
  24. 24.
    Rogers LR (2003) Cerebrovascular complications in cancer patients. Neurol Clin 21:167–192. doi: 10.1016/S0733-8619(02)00066-X PubMedCrossRefGoogle Scholar
  25. 25.
    Steiner I (1993) Nonbacterial thrombotic endocarditis-a study of 171 case reports. Cesk Patol 29:58–60PubMedGoogle Scholar
  26. 26.
    Gonzalez Quintela A, Candela MJ, Vidal C et al (1991) Non-bacterial thrombotic endocarditis in cancer patients. Acta Cardiol 46:1–9PubMedGoogle Scholar
  27. 27.
    Herrera dP, Esteban EE, Gimenez SJV, Pareja MA, Moscoso dP (2004) Nonbacterial thrombotic endocarditis as initial event of lung cancer. An Med Interna 21:495–497Google Scholar
  28. 28.
    Ojeda VJ, Frost F, Mastaglia FL (1985) Non-bacterial thrombotic endocarditis associated with malignant disease: a clinicopathological study of 16 cases. Med J Aust 42:629–631Google Scholar
  29. 29.
    Reisner SA, Brenner B, Haim N, Edoute Y, Markiewicz W (2000) Echocardiography in nonbacterial thrombotic endocarditis: from autopsy to clinical entity. J Am Soc Echocardiogr 13:876–881. doi: 10.1067/mje.2000.106070 PubMedCrossRefGoogle Scholar
  30. 30.
    Singhal AB, Topcuoglu MA, Buonanno FS (2002) Acute ischemic stroke patterns in infective and nonbacterial thrombotic endocarditis: a diffusion-weighted magnetic resonance imaging study. Stroke 33:1267–1273. doi: 10.1161/01.STR.0000015029.91577.36 PubMedCrossRefGoogle Scholar
  31. 31.
    Edoute Y, Haim N, Rinkevich D, Brenner B, Reisner SA (1997) Cardiac valvular vegetations in cancer patients: a prospective echocardiographic study of 200 patients. Am J Med 102:252–258. doi: 10.1016/S0002-9343(96)00457-3 PubMedCrossRefGoogle Scholar
  32. 32.
    Daniels SK, Brailey K, Priestly DH, Herrington LR, Weisberg LA, Foundas AL (1998) Aspiration in patients with acute stroke. Arch Phys Med Rehabil 79:14–19. doi: 10.1016/S0003-9993(98)90200-3 PubMedCrossRefGoogle Scholar
  33. 33.
    Ding R, Logemann JA (2000) Pneumonia in stroke patients: a retrospective study. Dysphagia 15:51–57PubMedGoogle Scholar
  34. 34.
    Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EEIII (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35–41PubMedGoogle Scholar
  35. 35.
    Quinones-Hinojosa A, Gulati M, Singh V et al (2003) Spontaneous intracerebral haemorrhage due to coagulation disorders. Neurosurg Focus 14:11. doi: 10.3171/foc.2003.14.6.11 CrossRefGoogle Scholar
  36. 36.
    Glass J (2006) Neurologic complications of lymphoma and leukaemia. Semin Oncol 33:342–347. doi: 10.1053/j.seminoncol.2006.03.004 PubMedCrossRefGoogle Scholar
  37. 37.
    Nguyen T, DeAngelis LM (2006) Stroke in cancer patients. Curr Neurol Neurosci Rep 6:187–191. doi: 10.1007/s11910-006-0004-0 PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2009

Authors and Affiliations

  • Oberndorfer Stefan
    • 1
    Email author
  • Nussgruber Vera
    • 1
  • Berger Otto
    • 1
  • Lahrmann Heinz
    • 1
  • Grisold Wolfgang
    • 1
  1. 1.Department Neurology and LBI-NeurooncologyKFJ-HospitalViennaAustria

Personalised recommendations